Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    Open Studies | "Severe Acute Respiratory Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Severe Acute Respiratory Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
2 Recruiting Respiratory Virus Hospitalization Study (FLU 003 Plus)
Conditions: Influenza;   Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV);   Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Intervention:
3 Not yet recruiting MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Interventions: Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo
4 Recruiting Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Condition: Middle East Respiratory Syndrome Coronavirus
Interventions: Biological: SAB-301;   Other: Normal (9%) Saline

Indicates status has not been verified in more than two years